Research Article

A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA

Table 4

The relation between risk score and clinical features.

Clinical featureRisk score
High risk (%)Low risk (%)

Age0.0440.835
 ≥58285 (26.27)280 (25.81)
 <58259 (23.87)261 (24.05)
T8.9300.030
 T1126 (11.65)153 (14.14)
 T2333 (30.78)294 (27.17)
 T359 (5.45)78 (7.21)
 T423 (2.13)16 (1.47)
N10.2500.017
 N0250 (23.47)296 (27.79)
 N1171 (16.06)152 (14.27)
 N272 (6.76)47 (4.41)
 N338 (3.57)39 (3.67)
M0.0030.960
 M0478 (51.73)425 (46.00)
 M111 (1.19)10 (1.08)
Stage5.3440.148
 I77 (7.25)104 (9.79)
 II309 (29.10)307 (28.91)
 III132 (12.43)114 (10.73)
 IV9 (0.85)10 (0.94)
Person neoplasm cancer status3.4770.062
 Tumor-free420 (43.66)448 (48.38)
 With tumor55 (5.94)39 (2.02)
PR status by IHC3.2660.071
 Negative184 (17.83)158 (15.31)
 Positive330 (31.98)360 (34.88)
ER status by IHC8.3630.004
 Negative138 (13.33)100 (9.66)
 Positive377 (36.43)420 (59.90)
HER-2 status by IHC1.0490.306
 Negative283 (39.42)274 (38.16)
 Positive86 (11.98)75 (10.44)